Mangalam Drugs & Organics

quarterly
yearly
ParticularsDec '22Mar '23Jun '23Sep '23Dec '23
Revenue63.4591.4087.4881.5997.34
Expenses62.9697.0497.7786.3397.29
EBITDA6.600.54-3.452.226.97
EBIT3.72-2.22-6.88-1.513.35
Profit Before Tax0.51-5.65-10.29-4.750.04
Net Profit0.43-4.39-9.54-3.560.50
Financial Ratios
Operating Profit Margin10.49%0.59%-3.97%2.73%7.19%
Net Profit Margin0.68%-4.86%-10.97%-4.38%0.52%
Earning Per Share (Diluted)0.27-2.77-6.02-2.250.32
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.8.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ